ℹ️
🇬🇧
Search
Search for publications relevant for "PPAR-ALPHA"
PPAR-ALPHA
Publication
Class
Person
Publication
Programmes
Export current view
publication
PPAR-alpha and insulin sensitivity
2006 |
First Faculty of Medicine
publication
Serum concentrations of novel metabolic regulator FGF-21 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet and PPAR-alpha agonist treatment
Publication without faculty affiliation
publication
The transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes
2007 |
Third Faculty of Medicine
publication
Plasma mannose-binding lectin is stimulated by PPAR alpha in humans
2012 |
First Faculty of Medicine
publication
Role of the PPAR alpha Leu162Val and PPAR gamma 2 Pro12Ala Gene Polymorphisms in Weight Change after 2.5-Year Follow-up in Czech Obese Women
2010 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Contribution of hepatic PPAR-alpha to the phenotype of lipoatrophic A-ZIP/F-1 mice
Publication without faculty affiliation
publication
Influence of PPAR-alpha on the level of insulin-like growth factor 1 and on the insulinoresistention
Publication without faculty affiliation
publication
The physiology of lipoatrophic mice: role of leptin, liver PPAR-alpha and genetic background
Publication without faculty affiliation
publication
PPAR-alpha and insulin sensitivity: the role of endocrine function of adipose tissue
Publication without faculty affiliation
publication
Serum concentration FGF-21 - a new metabolic control in patients with obesity and diabetes mellitus 2nd type: the impact of dietary intervention and administration of PPAR-alpha agonists
Publication without faculty affiliation
publication
Stimulation of PPAR alpha normalizes the skin lipid ratio and improves the skin barrier of normal and filaggrin deficient reconstructed skin
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Serum Metabolomics Reveals Irreversible Inhibition of Fatty Acid beta-Oxidation through the Suppression of PPAR alpha Activation as a Contributing Mechanism of Acetaminophen-Induced Hepatotoxicity
2009 |
First Faculty of Medicine
publication
WY14, 643, a peroxisome proliferator-activated receptor alpha (PPAR-alpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipotrophic A-ZIP/F-1 mice
2002 |
First Faculty of Medicine
publication
Human Urinary Metabolomic Profile of PPAR alpha Induced Fatty Acid beta-Oxidation
2009 |
First Faculty of Medicine
publication
Human Urinary Metabolomic Profile of PPAR alpha Induced Fatty Acid beta-Oxidation
2009 |
Publication without faculty affiliation
publication
The effect peroxisome proliferator-activated receptor alpha (PPAR-alpha) knockout on insulin sensitivity as studied by the hyperinsulinemiceuglycemic clamp technique
Publication without faculty affiliation
publication
The influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and endocrine function of adipose tissue in obese women with type 2 diabetes
Publication without faculty affiliation
publication
Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes
2007 |
First Faculty of Medicine
publication
Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-alpha agonist treatment
2011 |
First Faculty of Medicine
publication
Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome
2010 |
First Faculty of Medicine
publication
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study
2018 |
First Faculty of Medicine
publication
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
2009 |
First Faculty of Medicine
publication
Comparison of Early (2 Days) and Later (28 Days) Response of Adipose Tissue to Very Low-Calorie Diet in Obese Women
2016 |
Third Faculty of Medicine
publication
Influence of the lung mechanical ventilation with injurious parameters on 7-ketocholesterol synthesis in Sus Scrofa
2010 |
First Faculty of Medicine
publication
Control of Steroid 21-oic Acid Synthesis by Peroxisome Proliferator-activated Receptor alpha and Role of the Hypothalamic-Pituitary-Adrenal Axis
2010 |
First Faculty of Medicine
publication
Is it safe to combine PPAR agonists? A lesson from muraglitazar
2006 |
First Faculty of Medicine
publication
Identification of Noninvasive Biomarkers for Alcohol-Induced Liver Disease Using Urinary Metabolomics and the Ppara-null Mouse
2010 |
First Faculty of Medicine
publication
Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists
2007 |
Third Faculty of Medicine
publication
Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-α Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels
2006 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy
2022 |
First Faculty of Medicine